{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:57:51Z","timestamp":1789750671240,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:italic>In situ<\/jats:italic> pulmonary artery thrombosis (ISPAT) is a relatively rare but potentially life-threatening complication of systemic lupus erythematosus (SLE) in children. We report the case of a 12-year-old girl who presented with fever, chest pain, and dyspnea. Immune thrombocytopenia was identified due to purpura and menorrhagia 3 months before presentation with a lowest platelet count of 12\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L. The sudden onset of fever, chest pain, and dyspnea were misdiagnosed as hyperinflammatory responses caused by pneumonia; these symptoms ameliorated with glucocorticoid and antibiotic treatment. The reappearance of symptoms after dose reduction of glucocorticoids and the observation of bloody bronchoalveolar lavage fluid necessitated further evaluation. Pulmonary artery thrombosis\/embolism was identified using computed tomography pulmonary angiography and high D-dimer quantitative level of 4,118\u2005\u03bcg\/L (normal &amp;lt;252\u2005\u03bcg\/L). Ultrasonography of the deep and superficial veins of both lower limbs and renal veins revealed no thrombosis, suggesting the diagnosis of ISPAT. Further etiological evaluation revealed positive antinuclear antibodies, lupus anticoagulant, and anti-SSA antibodies, confirming SLE. Repeated normal urine analysis indicated that lupus nephritis was unlikely. Further, the negative anticardiolipin and anti-\u03b2<jats:sub>2<\/jats:sub> glycoprotein antibodies and temporary positive lupus anticoagulant suggested that antiphospholipid syndrome was unlikely. The patient received anticoagulants, glucocorticoids, hydroxychloroquine, and mycophenolate therapy. Her symptoms gradually improved, and she was discharged. At the 1-month follow-up, the thrombosis had resolved. During the 1-year follow-up, her condition remained well without SLE relapse. Our experience with this case emphasizes searching for SLE in the case of ISPAT and pulmonary hemorrhages. ISPAT can occur in children with SLE and may be caused by hyperinflammatory response during SLE flare.<\/jats:p>","DOI":"10.3389\/fped.2024.1341188","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T04:56:12Z","timestamp":1707368172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: In situ pulmonary artery thrombosis in a 12-year-old girl classified as systemic lupus erythematosus"],"prefix":"10.3389","volume":"12","author":[{"given":"Yong","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2141.2008.07243.x","article-title":"Clinical features and outcome of pulmonary embolism in children","volume":"142","author":"Biss","year":"2008","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1160\/TH17-08-0531","article-title":"Acute pulmonary embolism in a National Danish Cohort: increasing incidence and decreasing mortality","volume":"118","author":"Lehnert","year":"2018","journal-title":"Thromb Haemost"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/bloodadvances.2017013292","article-title":"Increasing rate of pulmonary embolism diagnosed in hospitalized children in the United States from 2001 to 2014","volume":"2","author":"Carpenter","year":"2018","journal-title":"Blood Adv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.chest.2021.09.019","article-title":"Acute management of high-risk and intermediate-risk pulmonary embolism in children: a review","volume":"161","author":"Ross","year":"2022","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1160\/TH16-07-0529","article-title":"Pulmonary embolism and in situ pulmonary artery thrombosis in paediatrics. A systematic review","volume":"117","author":"Rajpurkar","year":"2017","journal-title":"Thromb Haemost"},{"key":"B6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4274\/balkanmedj.galenos.2022.2022-3-46","article-title":"Pulmonary embolism in childhood: a multicenter experience from Turkey","volume":"39","author":"Hang\u00fcl","year":"2022","journal-title":"Balkan Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Groot","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2045894019869837","DOI":"10.1177\/2045894019869837","article-title":"Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature","volume":"9","author":"Trombetta","year":"2019","journal-title":"Pulm Circ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"617137","DOI":"10.3389\/fped.2020.617137","article-title":"Pulmonary involvement in children with systemic lupus erythematosus","volume":"8","author":"Dai","year":"2021","journal-title":"Front Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/adc.66.6.713","article-title":"Thrombosis in systemic lupus erythematosus: a French collaborative study","volume":"66","author":"Montes de Oca","year":"1991","journal-title":"Arch Dis Child"},{"key":"B11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1440-1754.2001.00673.x","article-title":"Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus","volume":"37","author":"Yuen","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/nep.13175","article-title":"Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome","volume":"23","author":"Nagata","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/PEC.0b013e31820d8dd4","article-title":"Pulmonary thromboembolism as the initial manifestation in a child with antiphospholipid syndrome in the emergency department","volume":"27","author":"Bhat","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1004053","DOI":"10.3389\/fped.2022.1004053","article-title":"Case report: a case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus","volume":"10","author":"Liu","year":"2023","journal-title":"Front Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00467-008-1037-1","article-title":"Pulmonary thrombosis as the first manifestation of systemic lupus erythematosus in a 14-year-old boy","volume":"24","author":"Harroche","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","volume":"76","author":"de Graeff","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/ard.2004.033100","article-title":"Lupus thrombocytopenia: clinical implications and prognostic significance","volume":"64","author":"Ziakas","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s42358-019-0062-z","article-title":"Comparison among ACR1997, SLICC and the new EULAR\/ACR classification criteria in childhood-onset systemic lupus erythematosus","volume":"59","author":"Rodrigues Fonseca","year":"2019","journal-title":"Adv Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-023-04833-0","article-title":"Systemic lupus erythematosus in children","author":"Chandwar","year":"2023","journal-title":"Indian J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/art.41093","article-title":"Complement activation in patients with probable systemic lupus erythematosus and ability to predict progression to American College of Rheumatology-classified systemic lupus erythematosus","volume":"72","author":"Ramsey-Goldman","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"i46","DOI":"10.1093\/rheumatology\/kew340","article-title":"Distinguishing infections vs flares in patients with systemic lupus erythematosus","volume":"56","author":"Ospina","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0961203310393378","article-title":"High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus","volume":"20","author":"Firooz","year":"2011","journal-title":"Lupus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"610257","DOI":"10.3389\/fmed.2020.610257","article-title":"Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus","volume":"7","author":"Amarnani","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.autrev.2019.102361","article-title":"Monogenic lupus: dissecting heterogeneity","volume":"18","author":"Omarjee","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3324\/haematol.2012.069195","article-title":"Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique","volume":"98","author":"van Langevelde","year":"2013","journal-title":"Haematologica"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.3390\/ijms21145086","article-title":"Pulmonary artery thrombosis: a diagnosis that strives for its independence","volume":"21","author":"Porembskaya","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/v15081681","article-title":"Spectrum of thrombotic complications in fatal cases of COVID-19: focus on pulmonary artery thrombosis in situ","volume":"15","author":"Babkina","year":"2023","journal-title":"Viruses"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1093\/rheumatology\/keaa857","article-title":"Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus","volume":"60","author":"Demir","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2011026","DOI":"10.4084\/MJHID.2011.026","article-title":"Beh\u00e7et\u2019s syndrome and thrombosis","volume":"3","author":"Seyahi","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijcard.2021.01.056","article-title":"A critical analysis of 57 cases of Hughes\u2013Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG)","volume":"331","author":"Emad","year":"2021","journal-title":"Int J Cardiol"},{"key":"B35","article-title":"Buerger disease","volume-title":"Statpearls","author":"Qaja","year":"2023"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40272-021-00484-w","article-title":"Managing antiphospholipid syndrome in children and adolescents: current and future prospects","volume":"24","author":"Islab\u00e3o","year":"2022","journal-title":"Paediatr Drugs"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.thromres.2019.05.013","article-title":"Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): a comparative study using DOAC Stop and ndexanet alfa","volume":"180","author":"Favaloro","year":"2019","journal-title":"Thromb Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/ijlh.12950","article-title":"Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban","volume":"41","author":"Platton","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fimmu.2019","article-title":"Reliability of lupus anticoagulant and anti-phosphatidylserine\/prothrombin autoantibodies in antiphospholipid syndrome: a multicenter study","volume":"10","author":"Sciascia","year":"2019","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.thromres.2021.03.022","article-title":"Pulmonary infarction in acute pulmonary embolism","volume":"202","author":"Kaptein","year":"2021","journal-title":"Thromb Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2214\/AJR.20.23399","article-title":"A review of clinical and imaging features of diffuse pulmonary hemorrhage","volume":"216","author":"Reisman","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1067\/j.cpradiol.2014.01.002","article-title":"Diffuse pulmonary hemorrhage: clues to the diagnosis","volume":"43","author":"Lichtenberger","year":"2014","journal-title":"Curr Probl Diagn Radiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.chest.2022.11.021","article-title":"Nebulized vs IV tranexamic acid for hemoptysis: a pilot randomized controlled trial","volume":"163","author":"Gopinath","year":"2023","journal-title":"Chest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1341188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T04:56:24Z","timestamp":1707368184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1341188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":45,"alternative-id":["10.3389\/fped.2024.1341188"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1341188","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"article-number":"1341188"}}